Tag
Featured Blog
blog image
September 13, 2024

Population Study: Stimulants Shown to Reduce Hospitalization and Suicidality

Swedish Population Study Suggests Stimulants Reduce Hospitalization and Suicidality, Have No Significant Effect on Work Disability

A meta-analysis of short-term, placebo-controlled, randomized clinical trials (Cortese et al. 2018), looking at both efficacy and safety, supported prescribing stimulants – methylphenidate use in children and adolescents and amphetamine use in adults – as first-choice medications. 

However, these were short-term studies, and they focused on relieving ADHD symptoms. What about longer-term outcomes, especially looking more broadly at functional impairment and overall quality of life? 

Sweden has a single-payer health insurance system that encompasses virtually every resident and is linked to national registers that enable researchers to conduct nationwide population studies. 

A joint Finnish-Swedish research team used Sweden’s registers to study outcomes for all individuals of working age, 16 to 65 years old, living in Sweden who had received a diagnosis of ADHD from 2006 through 2021. The resulting study cohort encompassed 221,714 persons with ADHD. 

The team adjusted for the following confounding variables: Genetics, baseline severity of symptoms, baseline comorbidities, temporal order of treatments (which medication was used as first, second, third, and so forth, including also nonuse of ADHD medications), time since cohort entry, and time-varying use of psychotropic drugs, including antidepressants, anxiolytics, hypnotics, mood stabilizers (carbamazepine, valproic acid, and lamotrigine), lithium, antipsychotics, and drugs for addictive disorders. 

With these adjustments, they discovered that amphetamine treatment was associated with a roughly 25% reduction in psychiatric hospitalization relative to unmedicated ADHD. Lisdexamphetamine was associated with a roughly 20% reduction, dexamphetamine with a 12% reduction, and methylphenidate with a 7% reduction. All four medications are stimulants

None of the non-stimulant medications – atomoxetine, guanfacine, clonidine – had any significant effect on psychiatric hospitalization. Nor did modafinil a drug that is not FDA approved for ADHD but is sometimes used when other drugs fail. 

Amphetamine was also associated with the greatest reduction in suicide attempts or deaths, with a roughly 40% decline relative to unmedicated ADHD. Dexamphetamine was associated with a roughly 30% decline and lisdexamphetamine with a roughly 25% decline. The stimulant methylphenidate was only associated with an 8% reduction, and modafinil had no significant effect. 

Surprisingly, non-stimulant medications were associated with significant increases in suicide attempts or deaths: 20% for atomoxetine, 65% for guanfacine, and almost double for clonidine

Amphetamine and lisdexamphetamine also reduced the risk of nonpsychiatric hospitalization by more than a third compared to unmedicated ADHD. Dexamphetamine was associated with a risk reduction of more than 25%, methylphenidate with 20% lesser risk.  

The non-stimulant atomoxetine was associated with a roughly 15% reduction in risk of nonpsychiatric hospitalization. But neither guanfacine nor clonidine had any significant effect. 

Turning to work disability, atomoxetine was the only ADHD medication associated with a reduction – a roughly 10% improvement. All other medications had no significant effect

The team concluded, “In this cohort study of adolescents and adults with ADHD, the use of medications for ADHD, especially lisdexamphetamine and other stimulants, was associated with decreased risk of psychiatric hospitalizations, suicidal behavior, and nonpsychiatric hospitalizations during periods when they were used compared with periods when ADHD medication was not used. Non-stimulant atomoxetine use was associated with decreased risk of work disability.” 

No items found.
blog image

Is Oxytocin During Childbirth an ADHD Risk Factor Later in Life?

Danish-Finnish countrywide population studies conclude that administration of oxytocin during childbirth is not a risk factor for ADHD

Oxytocin is a hormone released by the pituitary gland that stimulates the contraction of the uterus during labor. Synthetic oxytocin is widely administered during labor to supplement a birthing parent's supply and facilitate childbirth.

Previous studies have found an association between synthetic oxytocin and increased odds of ADHD in offspring.

A joint Danish and Finnish team used their countries' national registers to obtain countrywide cohorts encompassing over 577,000 Danes and over 945,000 Finns. Oxytocin had been administered in 31% of the Danish deliveries and 46% of the Finnish ones. Any children either diagnosed with ADHD or who received prescriptions for ADHD drugs were categorized as having ADHD.

As in previous studies, unadjusted results found a significant association with ADHD. Combining the two populations, children whose mothers had received oxytocin during labor were 16% more likely to later develop ADHD.

After adjusting for a series of confounders such as birth year, maternal age, education, marital status, parity, smoking in pregnancy, labor induction, gestational age, and intrauterine growth, the association dropped markedly, to an increased likelihood of barely 3%.

Looking at Denmark alone, the unadjusted risk was 9% greater, vanishing altogether after adjusting for confounders. In Finland, the unadjusted risk was 20% greater, declining to 4% after adjusting for confounders.

The authors noted that "Exposure to obstetric oxytocin is not a random process, and it is likely that other factors than the ones included here vary systematically between women treated vs not treated with oxytocin. ... Therefore, we find it most likely that the minor elevations in risk are due to uncontrolled and residual confounding, and thereby our results underscore the lack of a causal association between obstetric oxytocin exposure and ADHD."

February 1, 2022
blog image

New Estimates on Worldwide Prevalence of ADHD

Meta-analysis updates estimates of adult ADHD prevalence worldwide

Twenty studies covering a total of 107,282 participants reported the prevalence of persistent adult ADHD and found that the total pooled prevalence was 4.6%.

An international team of researchers conducted a comprehensive search of the peer-reviewed literature to perform a meta-analysis, with three aims:

1) assess the global prevalence of adult ADHD

2) explore possible associated factors

3) estimate the 2020 global population of persons with adult ADHD.

In doing so, they distinguished between studies requiring childhood-onset of ADHD to validate adult ADHD (persistent adult ADHD) and studies that make no such requirement and examine ADHD symptoms in adults regardless of previous childhood diagnosis (symptomatic adult ADHD).

The search yielded forty articles covering thirty countries. Twenty reported prevalence data on symptomatic adult ADHD, 19 on persistent adult ADHD, and one on both. Thirty-five studies were published in the last decade (2010-2019). Thirty-one included both urban and rural populations. Thirty-five had a quality score of six or above (out of ten). Twenty-five had sample sizes greater than a thousand.

Because the prevalence of ADHD is age-dependent, and different countries vary widely in the age structure of their populations, the authors adjusted country results for their structures. This allowed for meaningful global estimates of the prevalence of adult ADHD.

Twenty studies covering a total of 107,282 participants reported the prevalence of persistent adult ADHD. The pooled prevalence was 4.6%. After adjustment for the global population structure, the pooled prevalence was 2.6%, equivalent to roughly 140 million cases globally.

Twenty-one studies covering 50,098 participants reported on the prevalence of symptomatic adult ADHD. The pooled prevalence was 8.8%. After adjustment for the global population structure, the pooled prevalence was 6.7%, equivalent to roughly 366 million cases globally.

For persistent adult ADHD, adjusted prevalence declined steeply from 5% among 18- to 24-year-olds to 0.8% among those 60 and older.

For symptomatic adult ADHD, adjusted prevalence declined less steeply from 9% among 18- to 24-year-olds to 4.5% among that 60 and older.

In each case, subgroup analyses found no significant differences based on sex, urban or rural setting, diagnostic tool, DSM version, or investigation period, although pooled prevalence estimates of persistent adult ADHD from 2010 onward were almost twice the previous pooled prevalence estimates. For symptomatic adult ADHD, however, differences between WHO (World Health Organization) regions were highly significant, although the outliers(Southeast Asia at 25% and Eastern Mediterranean at 16%) were based on small samples(304 and 748 respectively).

In both cases, between-study heterogeneity was very high (over 97%). The authors noted, "the age of interviewed participants in the included studies was not unified, ranging from young adults to the elderly. Given the fact that the prevalence of adult ADHD decreases with advancing age, as revealed in previous investigations and our meta-regression, it is not surprising to observe such a diversity in the reported prevalence, and the considerable heterogeneity across included studies could not be fully ruled out by a priori selected variables, including diagnostic tool, DSM version, sex, setting, investigation period, WHO region, and WB [World Bank] region. The effects of other potential correlates of adult ADHD, such as ethnicity, were not able to be addressed due to the lack of sufficient information."

In both cases, there was also evidence of publication bias. The authors stated, "we did not try to eliminate publication bias in our analyses, because we deemed that an observed prevalence of adult ADHD that substantially differed from previous estimates was likely to have been published."

January 30, 2022
blog image

Breastfeeding associated with an almost 2/3 reduction in risk of ADHD

Breastfeeding associated with an almost 2/3 reduction in risk of ADHD

Preschool children who were never breastfed as infants are much more likely to have a medical diagnosis of ADHD than are children who were exclusively breastfed as infants.

The American Academy of Pediatrics (AAP) recommends exclusive breastfeeding for the first six months of infancy and continuation of breastfeeding for at least a year thereafter. Yet less than a third of U.S. mothers are still breastfeeding their infants at 12 months.

Previous studies have suggested that breastfeeding is associated with a lower risk of ADHD. But sample sizes have been small, and have not sufficiently explored confounding factors.

Using the Centers for Disease Control and Prevention's 2011-2012 National Survey of Children's Health, a research team analyzed data from a representative U.S. sample of 12,793 three- to five-year-old children.

The team excluded children with autism, developmental delays, speech problems, Tourette syndrome, epilepsy or seizure disorder, hearing problems, non-correctable vision problems, bone/joint/muscle problems, brain injury/concussion, or any current behavioral/conduct problems other than ADHD.

The team also adjusted for potential confounders. Some were demographic: sex, age, race, household income, the number of adults older than 18 years of age living in the home, and the number of children younger than the age of 18 years living in the home. Other variables related to health care access and delivery: insurance type, consistency of health insurance in the past 12 months, and a composite variable reflecting having a primary care provider, getting needed referrals, and effective care coordination. Exposure to secondhand smoke and preterm births were other key variables.

In the fully adjusted results, children who had been breastfed for at least six months were 62% less likely to be diagnosed with ADHD than those who had not (p = .0483). Moreover, each month of breastfeeding duration was associated with a significant additional 8% reduction in the odds of an ADHD diagnosis (95% confidence interval from 1% to 14%).

The authors concluded, "Preschool children who were never breastfed as infants were much more likely to have a medical diagnosis of ADHD than were children who were exclusively breastfed. Moreover, there seems to be a continuum of neuroprotective benefits associated with breastfeeding duration. Although these analyses cannot establish a causal relationship, our findings add to a growing body of literature-including several longitudinal studies and a meta-analysis-that suggests breastfeeding may reduce the likelihood of a child having later problems with inattention and/or hyperactivity. Although follow-up studies are needed to further examine the relationship between infant feeding and ADHD, these findings provide evidence to support the neurodevelopmental benefits of breastfeeding."

January 28, 2022
blog image

How does ADHD affect sexual function?

How does ADHD affect sexual function?

This review of seven studies addressing ADHD and sexuality points to a need for further research on ADHD and sexuality, with larger sample sizes.

This systematic review of the literature identified seven studies addressing ADHD and sexuality.

Sexual function

A Dutch study compared 136 persons with ADHD with two large surveys of the general Dutch population. They used both a self-report questionnaire, the Questionnaire for screening Sexual Dysfunction and a non-validated questionnaire especially constructed for the study. They found that males with ADHD reported a 50 percent higher rate of frequent masturbation than males in the general population. Both males and females were less than half as likely to be satisfied with their sex life. That was almost certainly linked to the fact that ADHD participants in the sample were less likely to be in a relationship.

A second study compared 79 ADHD participants with controls. Using a validated questionnaire, the Diagnostic Interview Schedule, to assess sexual function, they found a significant positive correlation between ADHD and the items "sex drive more than the average" and "recurrent thoughts about sex' by comparison with the control group.

A third study used two validated inventories “ the Derogates Sexual Functioning Inventory and the Social Sexual Orientation Inventory“ to assess sexual function among 27 young adult males. They found their sex drive to be higher than in the control group. 

Another study, also with 27 ADHD patients, compared them with two other groups, one with fiber mitosis (benign connective tissue cancers), and the other with both ADHD and fibromatosis. They used the validated Life Satisfaction Questionnaire to assess sexual function and found that those with ADHD reported lower sex life satisfaction.

On the other hand, the only large study, with over 14,000 participants, using a non-validated questionnaire to assess sexual function, found negligible associations between ADHD and the number of sexual partners, the frequency of having sex with one's partner, and the frequency of masturbation.

Sexual dysfunctions

The Dutch study mentioned above, comparing 136 ADHD outpatients with two large surveys of the general Dutch population, used a validated self-report questionnaire, the Questionnaire for screening Sexual Dysfunctions, and a non-validated questionnaire, specially designed for the study, the Questionnaire for screening Sexual Problems. It found the rate of sexual dysfunction among both males and females with ADHD to be over twice the level in the general population. Men were four times as likely to report problems with orgasm, 50 percent more likely to report premature ejaculation, and over ten times as likely to report sexual aversion. Women were over three times as likely to report sexual excitement problems, over twice as likely to report problems with orgasm, and over three times as likely to report sexual aversion. No significant differences existed between patients treated with psychostimulants and those without such treatment.

A second study, which used a validated questionnaire to compare 79 ADHD participants with controls, found significant correlations between ADHD and aversion to sex for men but none for women.

On the other hand, a third study, comparing 32 subjects with ADHD with 293 controls, found no significant difference in the prevalence of sexual dysfunctions. It used clinical interviews to assess ADHD, and a non-validated questionnaire to assess sexual dysfunctions.

A fourth study took a very different approach. It compared 38 individuals with premature ejaculation to 27 controls. It found more than ten times the rate of ADHD symptoms among those with premature ejaculation than in the control group. Significantly, it measures premature ejaculation directly, with a stopwatch.

Conclusion

The authors concluded, "This article provides the first systematic review of sexual health among subjects with ADHD and shows that the quality of sexual health among subjects with ADHD seems poor," but acknowledged "several limitations to our review. There are only a few studies for the topics we reviewed. For many studies, the sample size was small. The methodology and measurement instruments differed, which created a potential bias."

Indeed, the study with the largest sample size found negligible associations between ADHD and sexual function, contradicting studies with small sample sizes.

Only four of the studies, all with small sample sizes, examined sexual dysfunctions. Two found strong associations with ADHD, one found none, and the fourth had mixed results.

This points to a compelling need for further research on ADHD and sexuality, with larger sample sizes.

January 26, 2022
blog image

Is Antibiotic Use in Infancy a Risk-Factor for ADHD? How Do We Know?

Nationwide twin cohorts in the Netherlands and Sweden suggest antibiotic use in infants is not a risk factor for ADHD

There was no association found between ADHD and ASD diagnoses and early antibiotic use when environmental and genetic family factors were taken into account.

Proper development of the gut biota is important for the health of the brain and nervous system. It has been hypothesized that disturbances of gut bacteria by antibiotics could contribute to the development of neurodevelopmental disorders, including ADHD.

In the case of ADHD, studies to date have produced conflicting results. To tease out any familial confounding reflecting shared environment and genetics, a joint Dutch-Swedish team of researchers further tested the hypothesis through 7- to 12-year-old twins in the Netherlands Twin Register (25,781 twins) and 9-year-old twins in the Swedish Twin Registry (7,946 twins).

ADHD symptoms in the Netherlands cohort were derived from mothers' answers to the short Conners' Parental Rating Scale-Revised. For the Swedish cohort, ADHD was determined through the International Classification of Diseases codes for ADHD in the cross-linked National Patient Register.

Exposure to antibiotics during the first two years of childhood was determined by parent reports for the Netherlands twin cohort, and by prescription claims for antibiotics in the Swedish twin cohort.

Covariates were explored in both twin cohorts including educational attainment of parents, gender of the infant, birth weight, delivery mode, and asthma. Breastfeeding was also explored in the Dutch cohort.

In the unmatched analysis, comparing children with ADHD with non-related children without ADHD, early-life antibiotic use was associated with a significant 8% greater odds of ADHD in the Netherlands cohort and a significant 14% greater odds of ADHD in the Swedish cohort.

However, when limiting the analysis to matched monozygotic twins, the association disappeared altogether in both the Dutch and Swedish cohorts. Pooling both cohorts resulted in the same outcome. In all three cases, the odds flipped into a mildly negative association, but with no statistical significance.

Using higher cutoff values for ADHD symptoms made no difference.

The authors concluded, "In this large co-twin study performed in two countries, early-life antibiotic use was associated with increased risk of ADHD and ASD, but the results suggest that the association disappeared when controlled for shared familial environment and genetics, indicating that this association may be susceptible to confounding. Our results indicate that there is no association between ADHD and ASD diagnoses and early antibiotic use when environmental and genetic family factors are taken into account."

January 24, 2022
blog image

Interpreting Vehicular Accident Data in Relation To Those With ADHD

Nationwide population study finds high relative risk of traffic crashes among the elderly with ADHD, but with very low frequency, muddling interpretation of the results

Researchers from the Swedish Department of Global Public Health, the Swedish Transport Agency, and the Swedish National Road and Transport Research Institute collaborated in a nationwide population study of motor vehicle crashes among the elderly, defined as 65 and older.

They availed themselves of the country's all-encompassing national registers to identify the anonymized records of all such drivers from 2011 through 2016. That enabled them to compare crash records of those with known driving-impairing conditions with matched drivers who had no record of such conditions.

They looked only at road traffic crashes that resulted in injury to the driver or a passenger. For anyone with multiple crash records, they only looked at the first.

This was a case-control study, with two controls matched to each case wherever possible. For every case of a 65 or older driver involved in an injurious crash, the team randomly matched two individual controls by sex, birth year, municipality of residence, and other medical conditions. Place of residence was used to distinguish residents of large cities, who would tend to drive less frequently and in denser traffic, from those in small towns and rural areas. To minimize controls that never drive, only those with a driver's license and car were considered.

Of the thirteen medical conditions examined, elderly drivers with "ADHD, autism spectrum disorder, and similar conditions" had by far the highest odds of being in crashes that resulted in injury "at almost three times the rate of those without those conditions."

But note carefully the serious limitations in the data:

  • ADHD was bundled in with autism spectrum disorder and "similar conditions", making an unalloyed evaluation impossible.
  • Out of a total of 13,701 crashes, only 26 involved any of these conditions.
  • Because of the small number, the two-for-one matching broke down completely. Only 17 matched controls could be found, less than a third of the target of 52.
  • That means that despite a nationwide sample involving over 40,000 cases and controls, the sample size for "ADHD, autism spectrum disorder and similar conditions" was only 43.
The authors noted that while the high odds ratio "for ADHD, autism spectrum disorder, and similar conditions, are in line with previous studies on young adult drivers and adult drivers in this recent cohort of older, Swedish adults, such conditions are very uncommon compared to younger adults, suggesting likely under-diagnosis. Hence, the results should be interpreted with caution."
September 26, 2023
blog image

Connection Found Between Air Pollution and ADHD

Large longitudinal cohort study finds association between nitric oxide in air pollution and ADHD (hyperactivity)

Strong association found between gestational exposure to high levels of nitrogen oxide and later ADHD-hyperactive symptoms.

Taiwan's National Birth Registration database tracks every birth. Using all entries from 2005, random sampling was used to create the Taiwan Birth Cohort Study of 24,200 mother-infant pairs, which were geographically distributed and represented 12 percent of all births.

As this was an eight-year longitudinal study, there were dropouts, and 17,256 pairs completed the study. After excluding cases with fetal distress, smoking or alcohol use during pregnancy, and missing information on covariates, the final study population was 16,376.

Participants' addresses during gestation were geocoded to the township level, and local air pollution data was retrieved for the years 2004 to 2006 from air quality monitoring stations administered by Taiwan's Environmental Protection Administration. Every hour, each station records levels of nitric oxide (NO), nitrogen dioxide (NO2), nitrogen oxides (NOx), sulfur dioxide (SO2), carbon monoxide (CO), and particulate matter of diameter 10 μm or less (PM10).

The Taiwanese research team addressed several potential confounding factors: sex, maternal age, delivery method (cesarean section or not), birth in summer (June-August), urban or rural residence, and annual household income.

Because ADHD is primarily observable as hyperactivity rather than inattention among young children, the team focused on relating symptoms of hyperactivity to levels of air pollutants.

After adjusting for covariates, the team found no significant association between PM10 and SO2 levels and hyperactivity disorder. Nitrogen oxide levels, on the other hand, were associated with more than 25 percent higher odds of hyperactivity.

Breaking that down further, they found no significant association with NO2, and that the 25 percent higher odds were exclusive with nitric oxide (NO), a pollutant emitted by internal combustion engines in cars, trucks, and busses. NO is a free radical, meaning it has an unpaired electron that can damage the body because of its strong chemical reactivity.

The authors noted, "Our study has some limitations. First, hyperactivity was diagnosed based on a parent-reported physician or specialist diagnosis. Although we did not inquire which specialists made these diagnoses, they must have been a pediatrician, psychiatrist, or special education teacher. ... Second, the calculated exposure to ambient air pollutants was not an accurate personal exposure because it did not take indoor air pollutant levels and time-activity patterns into consideration. Applying personal environmental monitoring in such a large sample is impractical, especially when the subjects are pregnant."

Nevertheless, they emphasized, "this is the first study attempting to discover which component of NOx is more critical to the development of hyperactivity in offspring."

January 20, 2022
blog image

Reconsidering the Age-of-Onset Criterion in Older Adults Being Evaluated for ADHD

Reconsidering the Age-of-Onset Criterion in Older Adults Being Evaluated for ADHD

The current Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) requires evidence of symptom onset before age 12 to make a diagnosis of ADHD in adults.

A recently published clinical review questions the appropriateness of this criterion in older adults 50 years old and above. It sets forth several reasons:

  • ADHD was first recognized in the DSM in 1968, just over fifty years ago. Anyone over fifty is highly unlikely to have been diagnosed with ADHD in childhood, or even to have symptoms properly noticed.
  • It is well-established that memories both fade and change with time. Even among young adults, only about half can recall the age at which specific memories occurred. For older adults, the challenge is much greater, and that means questionnaire answers become unreliable.
  • Episodic memory among persons with ADHD is known to be impaired relative to controls, which further limits the reliability of memory, especially over extended periods.

On the other hand, the reason for the early onset criterion is to avoid any confusion with early neurodegenerative diseases such as Alzheimer's or Lewy body dementia, which have overlapping symptoms.

The authors suggest a possible fix:

  • For those over fifty, readjust the under-12 criterion to instead demonstrate the longstanding previous existence of ADHD symptoms, without forcing it to include the first eleven years of life. They call for research to determine how many years of previous symptoms would best distinguish ADHD symptoms from normal aging and the onset of dementia.
  • Establish a family history of ADHD. Heritability estimates suggest that ADHD occurs in roughly half the parents of people with ADHD, and about 15% of grandparents. That means that for persons over 50, having children and/or grandchildren with ADHD would lend greater weight to self-reported ADHD symptoms.
  • Noting that "cognitive functioning rating scales(e.g., the Barkley Deficits in Executive Functioning Scale) have shown to align robustly with ADHD symptoms," they "call for studies investigating the use of these rating scales in older adult samples, and particularly their discriminant validity relative to other late-life disorders affecting cognition."
  • This would be accompanied by careful screening for physical or psychiatric comorbidities, to reduce the risk of false positives.

It is unethical, the authors suggest, to deny care to older, presently undiagnosed adults, given the demonstrated poor outcomes associated with untreated ADHD.

January 16, 2022
blog image

Transcranial Direct Current Stimulation and Improving Response Inhibition

How effective is transcranial direct current stimulation at improving response inhibition?

Though initially offering some measurable results, further high-quality studies are needed to determine how effective tDCS may be in treating certain ADHD symptoms.

Inhibitory control is an essential cognitive control function whereby the prefrontal cortex blocks planned motor actions or interrupts motor actions already initiated by other parts of the brain. For example, someone might instinctually reach for a candy bar but then put it back upon thinking that eating it would conflict with a higher-level goal of cutting down on sugar consumption. Impairment of inhibitory control is a known characteristic of several psychiatric disorders, including ADHD.

Any generally safe treatment with the ability to at least partially reverse such impairment would therefore be useful. Researchers are currently experimenting with transcranial direct current stimulation, a non-invasive brain stimulation technique that uses a weak electrical current to stimulate specific regions of the brain.

What, then, do we know so far about its potential effectiveness for improving inhibitory control?

A team of experts at the University of Tübingen in Germany conducted a comprehensive search of the peer-reviewed medical literature to find out. They then performed a meta-analysis of 45 studies with a combined total of over 1,600 participants. All but four of the studies used sham or other active controls.

The overall meta-analysis found a significant but small improvement in response inhibition. But it also found evidence of publication bias. Adjusting for publication bias reduced the effect size in half, to a tiny but still significant improvement.

The meta-analysis relied on two behavioral tasks that require inhibitory control to measure response inhibition: the go-/no-task, and the stop-signal task. Separating these, there was no significant improvement in the go/no-go task performance. All the improvement was concentrated on the stop-signal task.

The authors noted, "A potential limitation of this meta-analysis is that we could not exhaustively model-dependent relationships between moderator variables (e.g., tDCS polarity and electrode placement)," and "Further high-quality studies are needed to investigate potential interactions between technical and functional parameters in tDCS research."

January 14, 2022
blog image

The Use of EEGs in Diagnosing Various Levels of Adult ADHD

Adult ADHD: How do those with the full syndrome compare with those who are subthreshold on executive functioning, and are EEGs of any use in diagnosis?

German researchers study how useful EEG markers may or may not be in the treatment of full-spectrum ADHD as compared to sub-threshold ADHD.

Noting that to date, no study investigated potential behavioral and neural markers in adults with subthreshold ADHD as compared to adults with full syndrome ADHD and healthy controls, the German team of researchers at the University of Tübingen out to do just that, recruiting volunteers through flyers and advertisements.

Their ADHD sample consisted of 113 adults between 18 and 60 years of age (mean age 38) who fulfilled the DSM-IV-TR criteria of ADHD and were either not on medication or a steady dose of medication over the prior two months.

Another 46 participants (also mean age 38), whose symptoms did not reach the DSM-IV-TR criteria, were assigned to the group with subthreshold ADHD.

The control sample was comprised of 42 healthy participants (mean age 37).

Individuals with schizophrenia, bipolar disorder, borderline personality disorder, epilepsy, or traumatic brain injury were excluded from the sample, as were those with current substance abuse or dependence.

All participants were German-speaking Caucasians. There were no significant differences in gender, age, education, or verbal/nonverbal intelligence among the three groups.

Participants first completed an online pre-screening, which was followed up with an interview to confirm the ADHD diagnosis.

ADHD impairs executive functions, "defined as the 'top-down' cognitive abilities for maintaining problem-solving skills to achieve future goals." The researchers explored three categories of executive functioning: 1) capacity for inhibition, "the ability to inhibit dominant, automatic, or prepotent responses when necessary- 2) ability to shift, enabling smooth switching between tasks or mental sets; and 3) ability to update, "updating and monitoring of working memory representations." Participants took a battery of neuropsychological tests to assess performance in each category.

Significant differences emerged between the group with ADHD and healthy controls in all measures except one: the STROOP Reading test. But there were no significant differences between participants suffering from subthreshold and full-syndrome ADHD. Nor were there any significant differences between those with subthreshold ADHD and healthy controls.

The researchers also recorded electroencephalograms(EEGs) for each participant. In healthy individuals, there is little to no association between resting-state EEG spectral power measures and executive functions. In individuals with ADHD, some studies have indicated increased theta-to-beta ratios, while others have found no significant differences. This study found no significant differences between the three groups.

The authors concluded, "The main results of the study can be summarized as follows: First, increased executive function deficits (in updating, inhibition, and shifting functions) could be observed in the full syndrome ADHD as compared to the healthy control group while, on the electrophysiological level, no differences in the theta to the beta ratio between these groups were found. Second, we observed only slightly impaired neuropsychological functions and no abnormal electrophysiological activity in the subthreshold ADHD sample. Taken together, our data suggest some practical uses of the assessment of objective cognitive markers but no additional value of examining electrophysiological characteristics in the diagnosis of subthreshold and full syndrome ADHD in adulthood."

They added, "These findings deeply question the value of including resting EEG markers into the diagnostic procedure and also have implications for standard neurofeedback protocols frequently used in the treatment of ADHD, where patients are trained to reduce their theta power while simultaneously increasing beta activity."

January 12, 2022
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.